In case you missed it, we celebrated Pi Day last week with the release of PyMOL 3.1.4. Download the new and improved PyMOL now to receive the limited edition PyMOL app icon, only available for a limited time. Download here: https://hubs.li/Q03c946L0
Schr?dinger
软件开发
New York，New York 52,185 位关注者
Transforming drug discovery and materials research
关于我们
Schr?dinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schr?dinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schr?dinger is deeply committed to investing in the science and talent that drive its computational platform. Schr?dinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com.
- 网站
-
https://www.schrodinger.com
Schr?dinger的外部链接
- 所属行业
- 软件开发
- 规模
- 501-1,000 人
- 总部
- New York，New York
- 类型
- 上市公司
- 创立
- 1990
地点
Schr?dinger员工
动态
-
We've baked up something exciting for Pi Day! PyMOL 3.1.4 includes feature upgrades and improvements, along with a limited edition app icon to celebrate our favorite science holiday. Download PyMOL 3.1.4 now and get the Pi Mole app icon for a limited time only: https://hubs.ly/Q03bT_Jw0
-
-
Designing protein degraders requires complex optimization across multiple parameters. Schr?dinger has been working with industry scientists to develop computational workflows that can address diverse challenges, from predicting ternary complexes to optimizing linker properties. Join our webinar on Wednesday, March 26th to learn more about the latest protein degrader modeling tools and a sneak peak of what’s to come. Register here: https://hubs.li/Q03bxNmK0
-
-
Schr?dinger is pleased to announce the appointment of Bridget van Kralingen to our Board of Directors. Read the press release here: https://hubs.li/Q03b38M90
-
-
Are you attending the NextGen Biomed Conference in London, United Kingdom? Stop by booth 48 to speak with Schr?dinger scientists and join our workshop on March 12, 12:05 PM GMT titled "Accelerating Biologics Design through Computational Modeling and Collaborative Enterprise Informatics.” Explore our solutions for biologics: https://lnkd.in/eYZVCfCR
-
-
Register now for Schr?dinger's European User Group Meeting on June 3-5, 2025 in Budapest, Hungary. This in-person event will convene Schr?dinger team members and customers from across Europe. The interactive program includes scientific presentations, workshops, and panel discussions, as well as networking opportunities and evening social events. Learn more and register: https://hubs.li/Q039qdmZ0
-
-
Today Schr?dinger announced that we have expanded our research collaboration with Eli Lilly and Company with the addition of another undisclosed target, building on the previously announced collaboration. Learn more about the collaboration and additional company updates in our fourth quarter and full-year 2024 financial results press release: https://hubs.li/Q038tbjF0 Listen to the LIVE webcast at 4:30PM today for an update on our progress: https://hubs.li/Q038tLxN0
-
-
Schr?dinger will announce fourth quarter and full-year 2024 financial results today. Join us at 4:30PM ET for an update on our progress. Listen to the LIVE webcast here: https://hubs.li/Q038jgmr0
-
-
Computational methods are revolutionizing drug discovery and becoming indispensable tools in the medicinal chemist's arsenal. In this Drug Hunter Flash Talk, Schr?dinger's Aleksey Gerasyuto will discuss the application of physics-based modeling to inform medicinal chemistry decisions across several drug discovery programs within our internal and collaborative portfolio. Join us for the talk on Thursday, February 27th at 11 AM EST to hear examples of how FEP+ has been employed for potency and selectivity modeling, enabling the efficient discovery and optimization of chemical matter. Register here: https://hubs.li/Q0381-vq0
-